Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC pediculicides

This article was originally published in The Tan Sheet

Executive Summary

NDMA submits citizen's petition to FDA and EPA on April 22, urging the agencies to "develop and implement a specific set of coordinating steps for the administrative transfer" of regulatory authority for pediculicides from EPA to FDA when the final OTC monograph on pediculicides becomes effective on Dec. 14. Actions requested in the petition echo those discussed at an April 14 "OTC feedback" meeting: an EPA stay of enforcement on FDA-labeled products prior to the effective date and a one-year grace period from FDA for EPA-labeled products in interstate commerce ("The Tan Sheet" April 18, p. 15). NDMA requested "expedited review" of the petition based on public health concerns and the "unique character of OTC pediculicide production and marketing"
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082790

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel